Research & Publications
The Marquez-Nostra Laboratory of Cancer Imaging and Therapeutics focuses on the development of radiolabeled antibodies for positron emission tomography (PET) and single photon emission tomography (SPECT) imaging of cancer biomarkers and the evaluation of investigational therapeutics in breast cancer, melanoma, and renal cell carcinoma. Such approach has the potential to predict response to corresponding targeted therapy and to get a global view of the expression of disease targets in the body noninvasively. We discover novel probes using phage display peptide/antibody fragment screening of new biomarkers for imaging and treatment of cancer. Finally, we are interested in developing targeted radionuclide therapy to overcome resistance to standard of care treatments.
Specialized keyword: imaging cancer
Radionuclide Imaging; Biomedical Research; Positron-Emission Tomography; Single Photon Emission Computed Tomography Computed Tomography